Emerging Company Profile
Adcentrx: new linker-payload combos for improved ADC therapeutic windows
Emerging Company Profile: Adcentrx debuts to develop ADCs using new linkers, drugs to improve safety, efficacy
Adcentrx emerges with CBC-led $50 million A round to develop ADCs with optimized antibody-drug-linker combinations for improved safety and efficacy.
Apr 29, 2021 | 2:02 AM GMT